GlassScriptPhysician profile
Olivia Nguh
NPI 1336409374
$3,686.81
in general payments reported to CMS, 2019-2025
15 companies · $1,851 in 2025
The $1,851 reported for 2025 was more than what 93% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $117 · 2022: $143 · 2023: $482 · 2024: $1,095 · 2025: $1,851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,400 · Education: $27.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,400.46 |
| Education | $27.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,013.56 | 2022-2025 | |
| Axsome Therapeutics, INC. | $437.92 | 2023-2025 | Auvelity, Sunosi |
| Otsuka America Pharmaceutical, INC. | $415.42 | 2024-2025 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Neurocrine Biosciences, INC. | $386.96 | 2021-2025 | Ingrezza |
| Alkermes, INC. | $346.93 | 2023-2025 | Aristada, Lybalvi, Aristada Initio |
| Supernus Pharmaceuticals, INC. | $287.24 | 2023-2025 | Qelbree, Qelbree |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $255.94 | 2025 | Caplyta |
| Lundbeck LLC | $197.95 | 2024-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| E.R. Squibb & Sons, L.L.C. | $86.68 | 2024-2025 | Cobenfy |
| Corium, LLC | $67.98 | 2023-2024 | Azstarys, Azstarys |
| Janssen Pharmaceuticals, INC | $64.28 | 2025 | Invega Sustenna |
| Teva Pharmaceuticals USA, INC. | $56.24 | 2024-2025 | Austedo Xr, Austedo Xr |
| Braeburn INC. | $25.32 | 2024 | Brixadi |
| Indivior INC. | $24.58 | 2025 | Sublocade |
| Collegium Pharmaceutical, INC. | $19.81 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olivia Nguh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.